欧州の不妊症 検査と治療市場予測　2021-2028年

EUROPE INFERTILITY TESTING & TREATMENT MARKET FORECAST 2021-2028

このレポートへお問合せ

レポート目次

Report Details

この調査レポートは欧州の不妊症 検査と治療市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The Europe infertility testing & treatment market is forecasted to grow with a CAGR of 10.73% over the estimated period of 2021 to 2028. The high awareness associated with infertility, the presence of advanced healthcare facilities, and the increasing age of conception and late marriages are among the key factors accredited to the regional market’s growth.
MARKET INSIGHTS
The Europe infertility testing & treatment market growth assessment includes the evaluation of Russia, Poland, Italy, France, the United Kingdom, Germany, Belgium, and the rest of Europe. As per the ‘Alarming Public Health Report on Infertility in France,’ published in 2018, exposure to toxic substances and environmental factors were considered the leading causes of infertility in men. The study found that sperm concentration plummeted by 1.9% annually, indicating a decline of more than 32% over the last 15 years. Moreover, the number of morphologically normal spermatozoids is decreasing in France, as well.
In Italy, obesity has been cited as a serious health issue over the years. According to the data issued by the Organization for Economic Co-operation and Development (OECD), nearly 1 in 10 people in the country are obese. However, this number is considerably lesser than the OECD average of 1 in 6 people. The estimations also indicate that the rate of being overweight is likely to increase by an additional 5% over the next decade. As a result, with the rise in obesity rates, the number of fertility cases also continue to grow. Thus, these factors are set to propel the Europe infertility testing & treatment market.
COMPETITIVE INSIGHTS
Some of the top companies operating in the market are Endo International PLC, Halotech DNA, Vitrolife AB, etc.
Our report offerings include:
– Explore key findings of the overall market
– Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
– Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
– Market Segmentation cater to a thorough assessment of key segments with their market estimations
– Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
– Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
– Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
– Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

目次

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING STRESS AND LIFESTYLE DISORDERS
3.1.2. INCREASED AGE OF CONCEPTION
3.1.3. INCREASING EFFECTIVENESS OF TREATMENTS
3.1.4. RISING GOVERNMENT SUPPORT
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF TESTING AND TREATMENT
3.2.2. INFERTILITY CONSIDERED A SOCIAL TABOO
3.2.3. POSSIBLE RISKS ASSOCIATED WITH INFERTILITY TREATMENTS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON INFERTILITY TESTING & TREATMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. KEY BUYING CRITERIA
4.6.1. TREATMENT OPTIONS
4.6.2. QUALITY OF MEDICAL PROCEDURES
4.6.3. PRICE OF TREATMENTS
4.6.4. SHIFT TOWARDS MEDICAL TOURISM
4.6.5. REIMBURSEMENT
4.7. VALUE CHAIN ANALYSIS
4.7.1. RAW MATERIAL PROCUREMENT
4.7.2. MANUFACTURING
4.7.3. SUPPLY LOGISTICS
4.7.4. DISTRIBUTION CHANNELS
4.7.5. END-USERS
5. MARKET BY GENDER
5.1. MALE
5.1.1. MALE INFERTILITY TESTING
5.1.1.1. DNA FRAGMENTATION
5.1.1.2. OXIDATIVE STRESS ANALYSIS
5.1.1.3. SPERM PENETRATION ASSAY
5.1.1.4. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
5.1.1.5. SPERM AGGLUTINATION
5.1.1.6. MICROSCOPIC EXAMINATION
5.1.1.7. OTHERS
5.1.2. MALE INFERTILITY TREATMENT
5.1.2.1. MEDICATION
5.1.2.2. ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY
5.2. FEMALE
5.2.1. FEMALE INFERTILITY TESTING
5.2.1.1. OVULATION TESTING
5.2.1.2. HYSTEROSALPINGOGRAPHY
5.2.1.3. LAPAROSCOPY
5.2.1.4. TRANSVAGINAL ULTRASOUND
5.2.1.5. OVARIAN RESERVE TESTING
5.2.1.6. HORMONAL LEVEL TESTING
5.2.1.7. OTHERS
5.2.2. FEMALE INFERTILITY TREATMENT
5.2.2.1. IVF WITH ICSI
5.2.2.2. IUI
5.2.2.3. IVF WITHOUT ICSI
5.2.2.4. SURROGACY
5.2.2.5. OTHERS
6. MARKET BY END-USER
6.1. FERTILITY AND SURGICAL CENTERS
6.2. HOSPITALS AND RESEARCH LABORATORIES
6.3. CRYOBANKS
7. GEOGRAPHICAL ANALYSIS
7.1. EUROPE
7.1.1. KEY GROWTH ENABLERS
7.1.2. KEY CHALLENGES
7.1.3. KEY PLAYERS
7.1.4. COUNTRY ANALYSIS
7.1.4.1. UNITED KINGDOM
7.1.4.2. GERMANY
7.1.4.3. FRANCE
7.1.4.4. ITALY
7.1.4.5. RUSSIA
7.1.4.6. BELGIUM
7.1.4.7. POLAND
7.1.4.8. REST OF EUROPE
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.2. COMPANY PROFILES
8.2.1. ADORFEM
8.2.2. BANGKOK IVF CENTER
8.2.3. COOK MEDICAL INC
8.2.4. COOPER SURGICAL
8.2.5. CREATE FERTILITY CENTRE
8.2.6. EMD GROUP (MERCK KGAA)
8.2.7. ENDO INTERNATIONAL PLC
8.2.8. ESCO MEDICAL
8.2.9. FERRING PHARMACEUTICALS
8.2.10. FERTILITY FIRST
8.2.11. FUJIFILM IRVINE SCIENTIFIC
8.2.12. GENEA LTD
8.2.13. HALOTECH DNA
8.2.14. HAMILTON THRONE LTD
8.2.15. IVFTECH
8.2.16. LABOTECT GMBH
8.2.17. OLYMPUS CORPORATION
8.2.18. PROGYNY
8.2.19. THERMO FISHER SCIENTIFIC INC
8.2.20. VITROLIFE AB

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – INFERTILITY TESTING & TREATMENT
TABLE 2: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS
TABLE 3: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 4: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 5: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 6: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 7: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 8: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 9: PROS AND CONS OF DNA SHARING METHODS
TABLE 10: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: LIST OF MERGERS & ACQUISITIONS
TABLE 23: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 24: LIST OF PARTNERSHIPS & AGREEMENTS

List of Figures

LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: KEY BUYING CRITERIA
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY GENDER, IN 2020
FIGURE 8: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE, IN 2020
FIGURE 10: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020
FIGURE 12: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY DNA FRAGMENTATION, 2021-2028 (IN $ MILLION)
FIGURE 13: CAUSES OF SPERM DNA FRAGMENTATION
FIGURE 14: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OXIDATIVE STRESS ANALYSIS, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY SPERM PENETRATION ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2021-2028 (IN $ MILLION)
FIGURE 17: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY SPERM AGGLUTINATION, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MICROSCOPIC EXAMINATION, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY MALE INFERTILITY TESTING, IN 2020
FIGURE 22: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY MEDICATION, 2021-2028 (IN $ MILLION)
FIGURE 23: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY & VARICOCELE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 24: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 25: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE, IN 2020
FIGURE 26: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 27: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TESTING, IN 2020
FIGURE 28: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OVULATION TESTING, 2021-2028 (IN $ MILLION)
FIGURE 29: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY HYSTEROSALPINGOGRAPHY, 2021-2028 (IN $ MILLION)
FIGURE 30: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
FIGURE 31: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY TRANSVAGINAL ULTRASOUND, 2021-2028 (IN $ MILLION)
FIGURE 32: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OVARIAN RESERVE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 33: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY HORMONAL LEVEL TESTING, 2021-2028 (IN $ MILLION)
FIGURE 34: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 35: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 36: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY FEMALE INFERTILITY TREATMENT, IN 2020
FIGURE 37: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITH ICSI, 2021-2028 (IN $ MILLION)
FIGURE 38: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY IUI, 2021-2028 (IN $ MILLION)
FIGURE 39: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY IVF WITHOUT ICSI, 2021-2028 (IN $ MILLION)
FIGURE 40: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY SURROGACY, 2021-2028 (IN $ MILLION)
FIGURE 41: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 42: EUROPE INFERTILITY TESTING & TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
FIGURE 43: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY FERTILITY AND SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
FIGURE 44: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY HOSPITALS AND RESEARCH LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 45: EUROPE INFERTILITY TESTING & TREATMENT MARKET, BY CRYOBANKS, 2021-2028 (IN $ MILLION)
FIGURE 46: EUROPE INFERTILITY TESTING & TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 47: UNITED KINGDOM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 48: GERMANY INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 49: FRANCE INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 50: ITALY INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 51: RUSSIA INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 52: BELGIUM INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 53: POLAND INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)
FIGURE 54: REST OF EUROPE INFERTILITY TESTING & TREATMENT MARKET, 2021-2028 (IN $ MILLION)

お問合せフォーム

プライバシーポリシーはこちらをご覧ください。